The Analysis of N-linked Glycans by MALDI QIT TOF Mass Spectrometry
Applications | 2013 | ShimadzuInstrumentation
The structural analysis of N-linked glycans is critical for understanding protein function, cell signaling and biopharmaceutical quality control. These carbohydrate modifications influence protein folding, stability and interactions. Conventional MALDI-TOF provides mass profiles but lacks the capability for in-depth structural elucidation, especially when distinguishing isomeric sugars and branching patterns.
This study demonstrates the application of a MALDI-QIT-TOF mass spectrometer for comprehensive characterization of N-linked glycans. Key goals included achieving step-wise MSn fragmentation, high mass accuracy and resolution across all stages, and sufficient sensitivity to analyze low-abundance glycans. The work also assessed the system’s ability to localize atypical sugar additions and determine linkage information via cross-ring cleavages.
Released N-linked glycans were obtained by PNGase F digestion of glycoproteins. Free oligosaccharides were labeled with 2-aminobenzamide (2AB) and co-crystallized with 2,5-dihydroxybenzoic acid (DHB) matrix for MALDI analysis.
Sequential MSn experiments on a 2AB-derivatized triantennary high-mannose glycan (m/z 2026 [M+Na]+) revealed stepwise losses of 162 Da (mannose) and 203 Da (GlcNAc), leading to clear identification of antenna composition. Modulating trap excitation highlighted additional low-mass fragments at higher energy, enriching structural insights. Analysis of an aberrant glycan species at m/z 1972 confirmed a terminal galactose addition by comparing MS/MS and MS3 spectra of normal and modified precursors. The system demonstrated detection down to 20 fmol sample amounts. Cross-ring cleavage ions provided linkage-specific fingerprints, as exemplified by combined peptide and glycan fragmentation of a synthetic peptidoglycan (5-MGP), enabling unambiguous assignment of sugar linkages and branching.
Advances may include coupling to liquid chromatography for enhanced separation, integration with ion mobility for isomer differentiation, and improved software for automated MSn spectral annotation. Novel matrices and derivatization techniques could further boost sensitivity and fragmentation specificity. Expanding clinical glycomics, regenerative-medicine glycoprofiling and robust biopharma quality control are promising application domains.
The AXIMA-QIT MALDI-QIT-TOF platform offers a powerful solution for detailed N-glycan structural analysis. Its combination of high resolution, mass accuracy and MSn fragmentation capability enables precise characterization of sugar composition, linkages and branching, meeting the demands of modern glycoproteomics and quality control workflows.
MALDI, LC/TOF, LC/MS, LC/MS/MS, LC/IT
IndustriesProteomics
ManufacturerShimadzu
Summary
Significance of the Topic
The structural analysis of N-linked glycans is critical for understanding protein function, cell signaling and biopharmaceutical quality control. These carbohydrate modifications influence protein folding, stability and interactions. Conventional MALDI-TOF provides mass profiles but lacks the capability for in-depth structural elucidation, especially when distinguishing isomeric sugars and branching patterns.
Objectives and Study Overview
This study demonstrates the application of a MALDI-QIT-TOF mass spectrometer for comprehensive characterization of N-linked glycans. Key goals included achieving step-wise MSn fragmentation, high mass accuracy and resolution across all stages, and sufficient sensitivity to analyze low-abundance glycans. The work also assessed the system’s ability to localize atypical sugar additions and determine linkage information via cross-ring cleavages.
Methodology and Used Instrumentation
Released N-linked glycans were obtained by PNGase F digestion of glycoproteins. Free oligosaccharides were labeled with 2-aminobenzamide (2AB) and co-crystallized with 2,5-dihydroxybenzoic acid (DHB) matrix for MALDI analysis.
- Instrument: Shimadzu AXIMA-QIT MALDI-Quadrupole Ion Trap-Time-of-Flight (MALDI-QIT-TOF)
- MALDI ion source for sensitive, singly charged [M+Na]+ ion generation
- Quadrupole ion trap enabling precursor selection (resolution ~1,000 FWHM at 1,000 Da) and MSn fragmentation
- TOF mass analyzer delivering high resolution (up to 9,000 FWHM) and accurate mass determination
- Variable excitation amplitude to tune fragmentation energy in MSn stages
Main Results and Discussion
Sequential MSn experiments on a 2AB-derivatized triantennary high-mannose glycan (m/z 2026 [M+Na]+) revealed stepwise losses of 162 Da (mannose) and 203 Da (GlcNAc), leading to clear identification of antenna composition. Modulating trap excitation highlighted additional low-mass fragments at higher energy, enriching structural insights. Analysis of an aberrant glycan species at m/z 1972 confirmed a terminal galactose addition by comparing MS/MS and MS3 spectra of normal and modified precursors. The system demonstrated detection down to 20 fmol sample amounts. Cross-ring cleavage ions provided linkage-specific fingerprints, as exemplified by combined peptide and glycan fragmentation of a synthetic peptidoglycan (5-MGP), enabling unambiguous assignment of sugar linkages and branching.
Benefits and Practical Applications
- High sensitivity and low chemical noise allow analysis of low-abundance glycans
- Singly charged ions simplify spectral interpretation for glycomics workflows
- MSn capability facilitates direct determination of sequence, branching and linkage without extensive chromatographic separation
- Applicable to glycoprotein QA/QC, biomarker discovery and biopharmaceutical characterization
Future Trends and Opportunities
Advances may include coupling to liquid chromatography for enhanced separation, integration with ion mobility for isomer differentiation, and improved software for automated MSn spectral annotation. Novel matrices and derivatization techniques could further boost sensitivity and fragmentation specificity. Expanding clinical glycomics, regenerative-medicine glycoprofiling and robust biopharma quality control are promising application domains.
Conclusion
The AXIMA-QIT MALDI-QIT-TOF platform offers a powerful solution for detailed N-glycan structural analysis. Its combination of high resolution, mass accuracy and MSn fragmentation capability enables precise characterization of sugar composition, linkages and branching, meeting the demands of modern glycoproteomics and quality control workflows.
References
- Glycoprotein Analysis Manual, Sigma-Aldrich Corporation
- Harvey DJ et al., Rapid Commun. Mass Spectrom. 2004;18:2997
- Martin SA, Brancia FL, Rapid Commun. Mass Spectrom. 2003;17:1358
- Sutton CW et al., Proc. 51st ASMS Conf., Montreal 2003
- Reinhold VN, Stallmach R, Proc. 50th ASMS Conf., Orlando 2002
- Ding J et al., Proc. Int. Soc. Optical Eng. 1999;3777:144
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
An MSn platform for detailed characterisation of both the peptide and the glycan moieties and the peptide/glycan linkage in glycoproteins
2012|Shimadzu|Posters
PO-CON1240E An MSn platform for detailed characterisation of both the peptide and the glycan moieties and the peptide/glycan linkage in glycoproteins. IMSC 2012 PTu-006 Helen V. Montgomery1, Matthew E. Openshaw2, Omar Belgacem2, Masaki Murase3, Koichi Tanaka3. 1 Shimadzu, Mass Spec.…
Key words
glycan, glycanhexnac, hexnacpeptide, peptidehex, hexcharacterisation, characterisationsimse, simsemoieties, moietiesmsn, msntransferrin, transferrinaga, agaplatform, platformtriplet, tripletdetailed, detailedanalyser, analyserdesialylated
Structural Elucidation of N-glycans Originating From Ovarian Cancer Cells Using High-Vacuum MALDI Mass Spectrometry
2013|Shimadzu|Posters
PO-CON1347E Structural Elucidation of N-glycans Originating From Ovarian Cancer Cells Using High-Vacuum MALDI Mass Spectrometry ASMS 2013 TP-708 Matthew S. F. Choo1,3; Roberto Castangia2; Matthew E. Openshaw2; Omar Belgacem2; Stuart M. Haslam1; Anne Dell1; 1 Department of Life Sciences, Faculty…
Key words
ovarian, ovariancancer, cancerglycan, glycanglycans, glycansmaldi, maldiantenna, antennafucosylated, fucosylatedfucose, fucoseoriginating, originatingelucidation, elucidationcells, cellsstructural, structuralfucosylation, fucosylationspectrometry, spectrometryvacuum
How to Determine Glycan Profiles of Biopharmaceuticals from Peptide Mapping Data
2021|Bruker|Applications
How to Determine Glycan Profiles of Biopharmaceuticals from Peptide Mapping Data A new and sensitive approach combining BioPharma Compass, PASEF and VIP-HESI Abstract Glycosylation is a common critical quality attribute (CQA) of therapeutic proteins and needs to be characterized during…
Key words
glycan, glycanpeptide, peptideglycopeptide, glycopeptidetryptic, trypticcompositions, compositionssearch, searchmapping, mappingpasef, pasefbruker, brukertimstof, timstofglycopeptides, glycopeptidesglycans, glycansspectra, spectrausing, usingwere
Analysis of Serum N-Glycans of Gene-KO Mouse Using MALDI-7090 and SialoCapper-ID Kit
2021|Shimadzu|Applications
Sialic Acid Stabilizing Kit for Linkage Isomer Discrimination: SialoCapper™-ID Kit MALDI-TOF Mass Spectrometer: MALDI-7090 Application News Analysis of Serum N-Glycans of Gene-KO Mouse Using MALDI-7090 and SialoCapper-ID Kit M. Inuzuka, T. Nishikaze User Benefits Sialic acid linkage isomer can…
Key words
sialic, sialicglycan, glycanlinkage, linkageblotglyco, blotglycosialocapper, sialocapperacid, acidkit, kitderivatization, derivatizationsialyltransferase, sialyltransferaseglycoproteins, glycoproteinssalsa, salsaglycans, glycansderivative, derivativereleased, releasedserum